Chemed Co. (NYSE:CHE) Shares Purchased by Impax Asset Management Group plc

Impax Asset Management Group plc increased its stake in Chemed Co. (NYSE:CHE) by 4.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 332,757 shares of the company’s stock after purchasing an additional 14,814 shares during the quarter. Impax Asset Management Group plc owned approximately 2.20% of Chemed worth $199,977,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. EntryPoint Capital LLC grew its stake in Chemed by 14.0% during the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after acquiring an additional 18 shares in the last quarter. Covestor Ltd lifted its holdings in shares of Chemed by 10.6% during the first quarter. Covestor Ltd now owns 219 shares of the company’s stock worth $141,000 after buying an additional 21 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after purchasing an additional 22 shares during the period. Ballentine Partners LLC increased its position in shares of Chemed by 4.1% during the third quarter. Ballentine Partners LLC now owns 655 shares of the company’s stock valued at $394,000 after purchasing an additional 26 shares during the period. Finally, Everpar Advisors LLC increased its position in shares of Chemed by 4.9% during the second quarter. Everpar Advisors LLC now owns 580 shares of the company’s stock valued at $315,000 after purchasing an additional 27 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In other Chemed news, EVP Nicholas Michael Westfall sold 1,713 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $569.35, for a total value of $975,296.55. Following the transaction, the executive vice president now owns 6,109 shares of the company’s stock, valued at approximately $3,478,159.15. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the transaction, the chief executive officer now owns 103,735 shares of the company’s stock, valued at $62,117,555.35. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the company’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $569.35, for a total value of $975,296.55. Following the transaction, the executive vice president now directly owns 6,109 shares in the company, valued at $3,478,159.15. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,144 shares of company stock valued at $3,002,419. 3.32% of the stock is currently owned by corporate insiders.

Chemed Price Performance

Shares of NYSE:CHE opened at $525.03 on Tuesday. The business’s fifty day moving average price is $584.37 and its two-hundred day moving average price is $567.22. Chemed Co. has a fifty-two week low of $523.33 and a fifty-two week high of $654.62. The stock has a market capitalization of $7.90 billion, a price-to-earnings ratio of 26.53, a price-to-earnings-growth ratio of 2.19 and a beta of 0.46.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The company had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business’s revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the company earned $5.32 earnings per share. Research analysts expect that Chemed Co. will post 22.41 EPS for the current fiscal year.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.